Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4.
暂无分享,去创建一个
Ying Sun | P. Raman | Courtney A. Cullis | S. Peluso | C. Blackburn | R. Gimeno | E. Tozzo | V. Kaushik | S. Punreddy | P. Tummino | S. Condon | B. Hubbard | James Brown | T. Jenkins | B. Guan | S. Balani | Hui Wu | Y. Ye | Tom Daniels | P. Sanchetti | Dong Yu Sun
[1] Ying Sun,et al. Targeted Deletion of Fatty Acid Transport Protein-4 Results in Early Embryonic Lethality* , 2003, Journal of Biological Chemistry.
[2] D. Bernlohr,et al. Characterization of the Acyl-CoA Synthetase Activity of Purified Murine Fatty Acid Transport Protein 1* , 2003, Journal of Biological Chemistry.
[3] D. Bernlohr,et al. FATP1 channels exogenous FA into 1,2,3-triacyl-sn-glycerol and down-regulates sphingomyelin and cholesterol metabolism in growing 293 cells DOI 10.1194/jlr.M200130-JLR200 , 2002, Journal of Lipid Research.
[4] S. Peikin,et al. Orlistat: its current status as an anti-obesity drug. , 2002, European journal of pharmacology.
[5] D. Bernlohr,et al. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. , 2001, Gene.
[6] C. Kappe. Recent advances in the Biginelli dihydropyrimidine synthesis. New tricks from an old dog. , 2000, Accounts of chemical research.
[7] B. Frohnert,et al. The Fatty Acid Transport Protein (FATP1) Is a Very Long Chain Acyl-CoA Synthetase* , 1999, The Journal of Biological Chemistry.
[8] N. Abumrad,et al. Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm. , 1999, Biochimica et biophysica acta.
[9] H. Lodish,et al. Identification of the major intestinal fatty acid transport protein. , 1999, Molecular cell.
[10] C. Kappe,et al. Determination of absolute configuration in 4-aryl-3, 4-dihydro-2(1H)-pyrimidones by high performance liquid chromatography and CD spectroscopy. , 1999, Chirality.
[11] N. Abumrad,et al. Membrane transport of long-chain fatty acids: evidence for a facilitated process. , 1998, Journal of lipid research.
[12] R. Chang,et al. Design and Synthesis of Novel α1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia , 1998 .
[13] J. Schaffer,et al. Substitution of Alanine for Serine 250 in the Murine Fatty Acid Transport Protein Inhibits Long Chain Fatty Acid Transport* , 1998, The Journal of Biological Chemistry.
[14] H. Lodish,et al. A family of fatty acid transporters conserved from mycobacterium to man. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[15] E. Hu,et al. Unprecedented Catalytic Three Component One-Pot Condensation Reaction: An Efficient Synthesis of 5-Alkoxycarbonyl- 4-aryl-3,4-dihydropyrimidin-2(1H)-ones , 1998 .
[16] C. Kappe. A Reexamination of the Mechanism of the Biginelli Dihydropyrimidine Synthesis. Support for an N-Acyliminium Ion Intermediate(1). , 1997, The Journal of organic chemistry.
[17] A. de Pover,et al. Inhibition of lipid absorption as an approach to the treatment of obesity. , 1997, Methods in enzymology.
[18] H. Lodish,et al. Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein , 1994, Cell.
[19] S. Sherif,et al. A convenient synthesis of thiazolopyrimidines, thiazolodipyrimidines and heterocyclothiazolopyrimidines , 1993 .
[20] C. Kappe,et al. Synthesis and reactions of biginelli compounds −5. Facile preparation and resolution of a stable 5-dihydropyrimidinecarboxylic acid. , 1992 .